Managing Adverse Events in RCC

July 27th 2021, 2:09pm


Kidney cancer expert, Dr Thomas E. Hutson, shares insight on managing adverse events resulting from combination therapy in RCC.

Common Questions on Medical Marijuana

July 26th 2021, 6:00pm


An expert discusses the most common reasons his patients ask him about medical marijuana.

Access to Molecular Testing in the Community

July 21st 2021, 5:48pm


Current barriers that impact patient access to comprehensive biomarker testing in the community and efforts underway to help advocate for increased accessibility to molecular assays moving forward.

Becoming Informed About Comprehensive Genomic Profiling

July 21st 2021, 4:05pm


Resources available to support patients and community oncologists who are interested in learning more and gaining access to comprehensive biomarker testing.

VaxEffect Test Can Determine Immune Response to COVID-19 Vaccination in Patients With Cancer

July 20th 2021, 9:00pm


The vaccine immune response monitoring platform can identify weak responses in patients with cancer and help determine the potential need for a booster shot.

Treatment Selection for the Management of RCC

July 20th 2021, 4:45pm


Thomas E. Hutson, DO, PharmD, discusses his approach to determining the optimal initial therapy for a patient with RCC.

Emerging Agents for the Treatment of RCC

July 20th 2021, 4:40pm


Urologic oncology expert, Dr Thomas E. Hutson, reviews additional agents and clinical trials in the pipeline for the treatment of RCC.

Educated Patient® Webinar: Gastrointestinal Stromal Tumor (GIST)

July 14th 2021, 9:30pm


View the full CURE® Educated Patient® Webinar: Gastrointestinal Stromal Tumor (GIST).

Waiting for Results and Processing Information From Biomarker Testing

July 14th 2021, 2:09pm


Cancer patients, Deborah and George, reflect on their emotions while waiting to receive back results from biomarker testing and explain what it was like processing the information delivered by their test results as presented by their oncologists.

George Labonte: Concerns Upon a Diagnosis of Medullary Thyroid Cancer

July 14th 2021, 2:01pm


George Labonte explains what it was like receiving a diagnosis of medullary thyroid cancer and describes his experience being recommended for biomarker testing and concerns surrounding testing for germline mutations.